Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
34.40
-3.02 (-8.07%)
Nov 7, 2025, 4:00 PM EST - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $105.54 million as of November 7, 2025. Its market cap has increased by 2,514.48% in one year.
Market Cap
105.54M
Enterprise Value
107.78M
1-Year Change
2,514.48%
Ranking
Category
Stock Price
$34.40
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $105.54M, an increase of 281.22%. That is a compound annual growth rate of 117.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 114.80M | 2,871.14% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 831.12B |
| Johnson & Johnson | 449.96B |
| AbbVie | 380.45B |
| UnitedHealth Group | 296.47B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.77B |
| Novo Nordisk | 215.64B |